Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans

Nature Reviews Immunology

Volumn 7, Issue 8, 2007, Pages 585-598

  Roncarolo, Maria Grazia ^a,b   Battaglia, Manuela ^a,c  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ANTIGEN; GAMMA INTERFERON; NITRIC OXIDE; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT VERSUS HOST DISEASE; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CD4+ CD25+ T LYMPHOCYTE; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; DENDRITIC CELL; ENTERITIS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; IPEX SYNDROME; LYMPHOCYTE DIFFERENTIATION; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SCURFY DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; WISKOTT ALDRICH SYNDROME;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CLINICAL TRIALS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY, ADOPTIVE; ISOANTIGENS; T-LYMPHOCYTES, REGULATORY;

EID: 34547214205     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2138     Document Type: Review

References (96)

1. Shevach, E. M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25, 195-201 (2006).
2. R1 cells were characterized for the first time.
3. - T cells. J. Clin. Invest. 112, 1437-1443 (2003).
4. + regulatory T cells in self-tolerance and autoimmune disease. Curr. Top. Microbiol. Immunol. 305, 51-66 (2006).
5. + regulatory T cells. Eur. J. Immunol. 32, 1621-1630 (2002).
6. + T cells. Eur. J. Immunol. 33, 579-587 (2003).
7. Danke, N. A., Koelle, D. M., Yee, C., Beheray, S. & Kwok, W. W. Autoreactive T cells in healthy individuals. J. Immunol. 172, 5967-5972 (2004).
8. Kitani, A., Chua, K., Nakamura, K. & Strober, W. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J. Immunol. 165, 691-702 (2000).
9. R1 cells compared with HLA-matched healthy controls.
10. Baecher-Allan, C. & Hafler, D. A. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 212, 203-216 (2006).
11. + T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.Arthritis Rheum. 43, 617-627 (2000).
12. Miura, Y. et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 104, 2187-2193 (2004). This study shows for the first time a significant reduction of FOXP3 mRNA levels in PBMCs from patients with GVHD compared with those without GVHD.
13. Rezvani, K. et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108, 1291-1297 (2006).
14. + regulatory T cells in patients with chronic graft-versus-host disease. Blood 106, 2903-2911 (2005).
15. high regulatory T cells. Blood 103, 2410-2416 (2004).
16. high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation. Exp. Hematol. 33, 894-900 (2005).
17. + regulatory T cells are numerically deficient in acute and chronic GvHD. Blood 107, 1717-1723 (2006).
18. Meloni, F. et al. Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. Transplant Proc. 35, 1523-1526 (2003).
19. Demirkiran, A. et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl. 12, 277-284 (2006).
20. + T cells in human kidney transplant recipients. J. Am. Soc. Nephrol. 14, 1643-1651 (2003).
21. + T cells correlated with the absence of GVHD and long-term tolerance.
22. Baker, K. et al. High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths. Bone Marrow Transplant. 23, 1123-1129 (1999).
23. Weston, L. E., Geczy, A. F. & Briscoe, H. Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD. Bone Marrow Transplant. 37, 207-212 (2005).
24. VanBuskirk, A. M. et al. Human allograft acceptance is associated with immune regulation. J. Clin. Invest. 106, 145-155 (2000).
25. Bacchetta, R. et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116, 1713-1722 (2006).
26. + natural regulatory T cells. J. Exp. Med. 204, 369-380 (2007).
27. + regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 199, 1285-1291 (2004).
28. Bleesing, J. J. et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 98, 2466-2473 (2001).
29. + regulatory T cells. J. Immunol. 170, 3939-3943 (2003).
30. Tang, Q. et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455-1465 (2004).
31. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204, 191-201 (2007).
32. + T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 105, 1828-1836 (2005).
33. + T lymphocytes. Blood 103, 4216-4221 (2004).
34. + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104, 3804-3812 (2004).
35. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196, 401-406 (2002).
36. + regulatory T cells significantly delays or even prevents GVHD in preclinical mouse models of BMT.
37. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest. 112, 1688-1696 (2003).
38. + T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β. J. Immunol. 163, 3684-3691 (1999).
39. 3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167, 1945-1953 (2001).
40. + regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol. 172, 6539-6544 (2004).
41. Reg cells.
42. Battaglia, M. et al. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55, 40-49 (2006).
43. Waldmann, H., Adams, E., Fairchild, P. & Cobbold, S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 212, 301-313 (2006).
44. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195, 603-616 (2002).
45. + regulatory T cells for clinical trials. Biol. Blood Marrow Transplant. 12, 267-274 (2006).
46. high regulatory T cells. Blood 104, 895-903 (2004).
47. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196, 1335-1346 (2002).
48. + regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177, 8338-8347 (2006).
49. + T reg cells. J. Exp. Med. 203, 1701-1711 (2006).
50. Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693-1700 (2006).
51. Reg cells.
52. Roncarolo, M. G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50 (2006).
53. Battaglia, M. & Roncarolo, M. G. Induction of transplantation tolerance via regulatory T cells. Inflamm. Allergy Drug Targets 5, 157-165 (2006).
54. + regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108, 390-399 (2006).
55. Achenbach, P., Bonifacio, E. & Ziegler, A. G. Predicting type 1 diabetes. Curr. Diab. Rep. 5, 98-103 (2005).
56. + regulatory T cells protects from lethal acute GVHD. Blood 105, 2220-2226 (2005).
57. Nguyen, V. H. et al. In vivo dynamics of regulatory T cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood 109, 2649-2656 (2007).
58. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172, 4676-4680 (2004).
59. + regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J. Immunol. 177, 6540-6547 (2006).
60. + regulatory T cells. Hum. Immunol. 66, 222-230 (2005).
61. + T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J. Immunol. 177, 7155-7163 (2006).
62. Wood, K. J. & Sawitzki, B. Interferon γ: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol. 27, 183-187 (2006).
63. Farrar, M. A. & Schreiber, R. D. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11, 571-611 (1993).
64. Tang, Q. et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nature Immunol. 7, 83-92 (2006).
65. + cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol. 173, 2942-2951 (2004).
66. + T reg cells impinge on autoimmune diabetes. J. Exp. Med. 202, 1387-1397 (2005).
67. Roncarolo, M. G., Battaglia, M. & Gregori, S. The role of interleukin 10 in the control of autoimmunity. J. Autoimmun. 20, 269-272 (2003).
68. + regulatory T cells responsible for protection against diabetes. Proc. Natl Acad. Sci. USA 101, 4572-4577 (2004).
69. + T regulatory cells and T regulatory type 1 cells. Diabetes 55, 1571-1580 (2006).
70. Chen, C., Lee, W. H., Zhong, L. & Liu, C. P. Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide. J. Immunol. 176, 3449-3460 (2006).
71. Battaglia, M., Gregori, S., Bacchetta, R. & Roncarolo, M. G. Tr1 cells: from discovery to their clinical application. Semin. Immunol. 18, 120-127 (2006).
72. + regulatory T cells in immunological tolerance to self and non-self. Nature Immunol. 6, 345-352 (2005).
73. + Tregs. J. Clin. Invest. 115, 3276-3284 (2005).
74. Singh, B. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190-200 (2001).
75. + regulatory T cells. Immunol. Rev. 212, 60-73 (2006).
76. + regulatory T cell activity: it takes (IL-) two to tango. Eur. J. Immunol. 35, 1336-1341 (2005).
77. + Tr cells. Blood 105, 1162-1169 (2005).
78. Levings, M. K. et al. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166, 5530-5539 (2001).
79. Ziegler, S. F. FOXP3: of mice and men. Annu. Rev. Immunol. 24, 209-226 (2006).
80. + T regulatory cells. Nature Immunol. 4, 337-342 (2003).
81. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783-1786 (2005).
82. + T cells selectively kill B lymphocytes. Blood 107, 3925-3932 (2006).
83. Grossman, W. J. et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589-601 (2004).
84. + regulatory T-cells inhibit the islet innate immune response and promote islet engraftment. Diabetes 55, 1011-1021 (2006).
85. + type 1 T regulatory subset through IFN-γ-secreting Th1 cells. J. Immunol. 177, 3606-3614 (2006).
86. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467-1477 (2004).
87. + regulatory T cells from nonobese diabetic mice. J. Immunol. 175, 3053-3059 (2005).
88. Chen, C., Lee, W. H., Yun, P., Snow, P. & Liu, C. P. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J. Immunol. 171, 733-744 (2003).
89. You, S. et al. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. J. Immunol. 173, 6777-6785 (2004).
90. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl Acad. Sci. USA 99, 8213-8218 (2002).
91. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712-4716 (2002).
92. + regulatory T cells. Arthritis Rheum. 52, 2212-2221 (2005).
93. Cong, Y., Weaver, C. T., Lazenby, A. & Elson, C. O. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169, 6112-6119 (2002).
94. Scalapino, K. J., Tang, Q., Bluestone, J. A., Bonyhadi, M. L. & Daikh, D. I. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 177, 1451-1459 (2006).
95. + regulatory T cells. Nature Immunol. 4, 330-336 (2003).
96. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493-3499 (2002).